Continuous positive airway pressure delivered by oronasal mask may not be effective for obstructive sleep apnoea.

REFERENCES 1 Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009; 33: 871–881. 2 Ködmön C, Hollo V, Huitric E, et al. Multidrugand extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area. Eurosurveillance 2010; 15: 19519. 3 Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007; 30: 623–626. 4 Raviglione MC, Uplekar MW. WHO’s new Stop TB Strategy. Lancet 2006; 367: 952–955. 5 Capstick TG, Laycock D, Lipman MC, et al. Treatment interruptions and inconsistent supply of anti-tuberculosis drugs in the United Kingdom. Int J Tuberc Lung Dis 2011; 15: 754–760. 6 Sotgiu G, Centis R, D’ambrosio L, et al. Development of a standardised tool to survey MDR-/XDR-TB case management in Europe. Eur Respir J 2010; 36: 208–211. 7 Miravitlles M, Ferrara G, Lange C, et al. TB or not TB: update from the ERS Respiratory Infection Assembly 10. Eur Respir J 2010; 36: 665–670. 8 Sotgiu G, D’Ambrosio L, Centis R, et al. TB and M/XDR-TB infection control in European TB reference centres: the Achille’s heel? Eur Respir J 2011; 38: 1221–1223. 9 Migliori GB, Sotgiu G, D’Ambrosio L, et al. TB and MDR/XDR-TB in European Union and European Economic Area Countries: managed or mismanaged? Eur Respir J 2012; 39: 619–625. 10 Migliori GB, Sotgiu G, Blasi F, et al. European Union Standards for Tuberculosis Care. Eur Respir J 2011; 38: 493–495. 11 Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516–528.